dpDARSH PHARMALINKREGULATORY CONSULTANCY
All services

CMC LIFECYCLE & CHANGE

Technical change.
Regulatory clarity.

Align manufacturing and testing changes with supporting evidence, market-specific filing requirements and implementation dependencies.

When a technical change needs a regulatory plan

A site transfer, testing change or stability update may affect several markets with different submission and implementation requirements. A technically ready change still needs a coordinated regulatory assessment and decision trail.

A defined starting point: change-impact assessment

Agree the proposed change, current registered position, affected product presentations and markets. Review the available supporting information and identify the questions that need to be resolved with your Quality, Manufacturing, Supply and regulatory colleagues.

What you receive

From assessment to delivery

Further support can include variation or supplement planning, critical review of submission content, authority-response coordination and tracking of post-approval commitments. Responsibilities and review steps are agreed with your team before work begins.

Working alongside your technical functions

Remote support is designed for pharmaceutical and biotechnology companies and CRO or consultancy partners. Prior experience spans small molecules, biologics, RNAi and combination products; the scope of each assignment reflects the actual product and technical requirements.

Decisions based on the actual change

Classification, evidence requirements and implementation conditions must be checked against current requirements and the approved dossier. Scope, fees, availability and timelines are agreed after a non-confidential discussion; authority outcomes cannot be guaranteed.

A useful next step

Share a short, non-confidential outline of your product, markets and timeline.

Discuss your project

Explore the manufacturing-transfer case study